Research Correspondence

DOI: 10.4244/EIJ-D-26-00271

Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis

Nahyr Sofía Lugo-Fagundo1, MD; Ali H. Dakroub2, MD; Benjamin Hibbert3, MD; Pedro Villablanca4, MD; Marquand Patton5, DO; Sripal Bangalore6, MD; Mohammed Qintar7, MD; Stephanie El-Hajj8, MD; Paul Sorajja9, MD; Nadira Hamid9, MD; Evin Yucel10, MD; Larry Baddour11, MD; Pradeep Yadav12, MD; Sahil Parikh13, MD; Sanjum Sethi13, MD; Abdallah El Sabbagh1, MD; on behalf of the CLEAR-IE investigators

Catheter-based mechanical aspiration has emerged as a percutaneous strategy for vegetation debulking in select patients with right-sided infective endocarditis, with the CLEAR-IE registry demonstrating favourable procedural outcomes.1 The role of percutaneous mechanical aspiration (PMA) in left-sided infective endocarditis (LSIE), however, remains uncertain. In this analysis from the CLEAR-IE registry, we sought to evaluate the feasibility and safety of PMA in LSIE.

CLEAR-IE is a multicentre longitudinal registry, initiated in June 2022, to study the outcomes of PMA in infective endocarditis (IE). The design and methods of the CLEAR-IE registry have been described previously.1 Patients were included if they met the modified Duke criteria for IE and underwent PMA, performed at the clinicians’ discretion in the absence of protocol-based guidance. Baseline, procedural, and outcome data were retrospectively collected using standardised case report forms, and all sites obtained institutional review board approval. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Patients who underwent left-sided PMA were included, while those treated exclusively for right-sided IE or with incomplete outcome data were excluded. Procedural...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Receive our newsletter


Key metrics

Suggested by Cory
Trending articles
334.45

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
83.8

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
37.95

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
28.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
28.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.25

State-of-the-Art

10.4244/EIJ-D-24-00387 Jul 21, 2025
Advances in coronary imaging of atherosclerotic plaques
Garcia-Garcia H et al
free
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved